BODIPY-Based Molecules for Biomedical Applications.
Sarasija DasSudipto DeySanujit PatraArindam BeraTotan GhoshBibin PrasadKapil Dev SayalaKrishnendu MajiAnjan BediSashi DebnathPublished in: Biomolecules (2023)
BODIPY (4,4-difluoro-4-bora-3a,4a-diaza-s-indacene) derivatives have attracted attention as probes in applications like imaging and sensing due to their unique properties like (1) strong absorption and emission in the visible and near-infrared regions of the electromagnetic spectrum, (2) strong fluorescence and (3) supreme photostability. They have also been employed in areas like photodynamic therapy. Over the last decade, BODIPY-based molecules have even emerged as candidates for cancer treatments. Cancer remains a significant health issue world-wide, necessitating a continuing search for novel therapeutic options. BODIPY is a flexible fluorophore with distinct photophysical characteristics and is a fascinating drug development platform. This review provides a comprehensive overview of the most recent breakthroughs in BODIPY-based small molecules for cancer or disease detection and therapy, including their functional potential.
Keyphrases
- fluorescent probe
- living cells
- papillary thyroid
- photodynamic therapy
- squamous cell
- healthcare
- public health
- squamous cell carcinoma
- lymph node metastasis
- high resolution
- working memory
- stem cells
- high throughput
- mass spectrometry
- small molecule
- human health
- bone marrow
- climate change
- young adults
- risk assessment
- health promotion
- real time pcr